Figure 9.The mechanism summary diagram. AS and ASP could downregulate the expression of IL17A, and inhibit the activation of p38/MAPK pathway induced by abnormal cytokines and ROS, thereby ameliorating the aberrant levels of Bad, Bax and Bcl-2, and rectifying the abnormal apoptosis of bone marrow hematopoietic stem cells.
